Roby Paul Bhattacharyya, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Bacterial | 3 | 2019 | 399 | 1.090 |
Why?
|
Bacteria | 6 | 2020 | 1761 | 1.060 |
Why?
|
Campylobacter jejuni | 1 | 2017 | 23 | 0.780 |
Why?
|
Campylobacter Infections | 1 | 2017 | 31 | 0.780 |
Why?
|
Nucleic Acid Hybridization | 2 | 2019 | 1499 | 0.760 |
Why?
|
Drug Resistance, Bacterial | 3 | 2019 | 1002 | 0.710 |
Why?
|
Hepatitis, Autoimmune | 1 | 2017 | 118 | 0.680 |
Why?
|
Liver Failure, Acute | 1 | 2017 | 163 | 0.670 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 747 | 0.670 |
Why?
|
Viruses | 1 | 2018 | 296 | 0.660 |
Why?
|
Microbial Sensitivity Tests | 2 | 2019 | 1804 | 0.600 |
Why?
|
Bacteremia | 2 | 2017 | 920 | 0.570 |
Why?
|
Tuberculosis, Splenic | 1 | 2011 | 2 | 0.500 |
Why?
|
Communicable Diseases | 1 | 2018 | 688 | 0.490 |
Why?
|
Fever of Unknown Origin | 1 | 2011 | 91 | 0.460 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 6225 | 0.350 |
Why?
|
Pheromones | 1 | 2006 | 80 | 0.330 |
Why?
|
Saccharomyces cerevisiae Proteins | 4 | 2006 | 2052 | 0.330 |
Why?
|
Protein Kinases | 3 | 2006 | 1688 | 0.320 |
Why?
|
MAP Kinase Signaling System | 3 | 2006 | 1553 | 0.280 |
Why?
|
Dyspnea | 1 | 2011 | 1137 | 0.280 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2006 | 1416 | 0.270 |
Why?
|
DNA, Bacterial | 2 | 2018 | 1559 | 0.250 |
Why?
|
Protein Conformation | 2 | 2006 | 4176 | 0.220 |
Why?
|
Weight Loss | 1 | 2011 | 2093 | 0.220 |
Why?
|
Saccharomyces cerevisiae | 3 | 2006 | 2933 | 0.210 |
Why?
|
Fungal Proteins | 2 | 2006 | 979 | 0.200 |
Why?
|
Mycobacterium tuberculosis | 3 | 2019 | 1670 | 0.200 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 246 | 0.200 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 329 | 0.190 |
Why?
|
Alanine | 1 | 2020 | 537 | 0.190 |
Why?
|
Host-Parasite Interactions | 1 | 2019 | 269 | 0.190 |
Why?
|
Jaundice | 1 | 2017 | 94 | 0.190 |
Why?
|
Mycobacterium | 1 | 2019 | 246 | 0.180 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 188 | 0.180 |
Why?
|
Ribonucleases | 1 | 2017 | 286 | 0.170 |
Why?
|
Liver Function Tests | 1 | 2017 | 537 | 0.170 |
Why?
|
Tularemia | 1 | 2016 | 45 | 0.170 |
Why?
|
Ribotyping | 1 | 2015 | 33 | 0.170 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2017 | 277 | 0.160 |
Why?
|
Myocarditis | 1 | 2020 | 494 | 0.160 |
Why?
|
Gene Library | 2 | 2017 | 1101 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2445 | 0.160 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 638 | 0.160 |
Why?
|
Skin Ulcer | 1 | 2016 | 125 | 0.160 |
Why?
|
Dengue Virus | 1 | 2017 | 187 | 0.150 |
Why?
|
Phylogeny | 2 | 2019 | 2608 | 0.150 |
Why?
|
Lymphatic Diseases | 1 | 2016 | 329 | 0.150 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 250 | 0.150 |
Why?
|
Protein Folding | 1 | 1999 | 988 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 2 | 2019 | 1306 | 0.140 |
Why?
|
Inservice Training | 1 | 2016 | 414 | 0.140 |
Why?
|
beta-Lactams | 1 | 2014 | 162 | 0.130 |
Why?
|
Microfluidics | 1 | 2017 | 501 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 437 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2017 | 1890 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2017 | 840 | 0.130 |
Why?
|
Cuba | 1 | 2011 | 37 | 0.120 |
Why?
|
Genome, Bacterial | 1 | 2017 | 732 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 1672 | 0.120 |
Why?
|
DNA, Viral | 1 | 2018 | 2305 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 912 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3309 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3356 | 0.110 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1354 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 760 | 0.110 |
Why?
|
RNA | 1 | 2019 | 2427 | 0.110 |
Why?
|
Cause of Death | 1 | 2020 | 3292 | 0.110 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1573 | 0.100 |
Why?
|
Protein Structure, Secondary | 2 | 2006 | 1363 | 0.100 |
Why?
|
RNA, Viral | 1 | 2017 | 2610 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 977 | 0.100 |
Why?
|
Models, Molecular | 5 | 2006 | 5810 | 0.100 |
Why?
|
Tuberculosis | 1 | 2019 | 1557 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9355 | 0.090 |
Why?
|
Delirium | 1 | 2017 | 1118 | 0.090 |
Why?
|
Sepsis | 1 | 2020 | 2048 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2457 | 0.090 |
Why?
|
Binding Sites | 3 | 2006 | 6603 | 0.090 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 598 | 0.090 |
Why?
|
Myocardium | 1 | 2020 | 4877 | 0.090 |
Why?
|
Radiography | 1 | 2017 | 7102 | 0.080 |
Why?
|
Emigrants and Immigrants | 1 | 2011 | 364 | 0.080 |
Why?
|
Phenotype | 2 | 2019 | 14781 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2569 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2005 | 530 | 0.080 |
Why?
|
Signal Transduction | 2 | 2006 | 23610 | 0.080 |
Why?
|
Genotype | 1 | 2019 | 12726 | 0.070 |
Why?
|
Allosteric Regulation | 1 | 2006 | 444 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13357 | 0.070 |
Why?
|
Spleen | 1 | 2011 | 2572 | 0.070 |
Why?
|
Crystallography, X-Ray | 2 | 2006 | 2159 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2019 | 13819 | 0.070 |
Why?
|
Eukaryotic Cells | 1 | 2004 | 210 | 0.070 |
Why?
|
Amino Acid Motifs | 1 | 2006 | 1019 | 0.070 |
Why?
|
Humans | 17 | 2020 | 622221 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2006 | 4412 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2017 | 4065 | 0.060 |
Why?
|
Base Sequence | 1 | 2015 | 14119 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2006 | 4046 | 0.060 |
Why?
|
Genomics | 1 | 2017 | 4235 | 0.060 |
Why?
|
Proline | 1 | 2003 | 435 | 0.060 |
Why?
|
Protein Engineering | 1 | 2004 | 554 | 0.060 |
Why?
|
Cathepsin L | 1 | 2020 | 86 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 1999 | 9791 | 0.060 |
Why?
|
Evolution, Molecular | 2 | 2006 | 1907 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 1999 | 152 | 0.050 |
Why?
|
Lung | 1 | 2017 | 8489 | 0.050 |
Why?
|
Horses | 1 | 1999 | 263 | 0.050 |
Why?
|
Viscosity | 1 | 1999 | 341 | 0.050 |
Why?
|
Protein Binding | 3 | 2006 | 9994 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2020 | 8215 | 0.050 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1547 | 0.050 |
Why?
|
Models, Biological | 2 | 2006 | 10231 | 0.050 |
Why?
|
Down-Regulation | 1 | 2006 | 3273 | 0.050 |
Why?
|
Dimerization | 1 | 1999 | 978 | 0.040 |
Why?
|
Thermodynamics | 1 | 1999 | 694 | 0.040 |
Why?
|
Soil Microbiology | 1 | 2017 | 82 | 0.040 |
Why?
|
Heart Failure | 1 | 2017 | 7871 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 1 | 1999 | 777 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2020 | 850 | 0.040 |
Why?
|
Clavulanic Acid | 1 | 2014 | 23 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1067 | 0.040 |
Why?
|
Dengue | 1 | 2017 | 217 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 781 | 0.040 |
Why?
|
Organizational Policy | 1 | 2016 | 439 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2017 | 880 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2910 | 0.040 |
Why?
|
Carbapenems | 1 | 2014 | 124 | 0.040 |
Why?
|
Phosphorylation | 1 | 2006 | 8900 | 0.040 |
Why?
|
Pandemics | 2 | 2020 | 3742 | 0.030 |
Why?
|
src Homology Domains | 2 | 2004 | 360 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2020 | 1021 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3317 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 19609 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 5131 | 0.030 |
Why?
|
beta-Lactamases | 1 | 2014 | 430 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2683 | 0.030 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 505 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 14896 | 0.030 |
Why?
|
Up-Regulation | 1 | 2020 | 4370 | 0.030 |
Why?
|
Kinetics | 1 | 1999 | 7091 | 0.030 |
Why?
|
Animals | 6 | 2019 | 167159 | 0.030 |
Why?
|
Monocytes | 1 | 2020 | 2637 | 0.030 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1405 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2005 | 20037 | 0.030 |
Why?
|
Fever | 1 | 2016 | 1447 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2017 | 1376 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2362 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2004 | 3389 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3749 | 0.020 |
Why?
|
Mutation | 2 | 2017 | 26892 | 0.020 |
Why?
|
Female | 4 | 2020 | 349886 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8337 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 2946 | 0.020 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2014 | 816 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 4347 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2005 | 46 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 11666 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 8040 | 0.020 |
Why?
|
Peptides | 1 | 1999 | 4468 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10024 | 0.020 |
Why?
|
Aged | 1 | 2017 | 149815 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12699 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 2946 | 0.020 |
Why?
|
Middle Aged | 3 | 2016 | 203146 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 8530 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6425 | 0.020 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 494 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2004 | 754 | 0.020 |
Why?
|
Boston | 1 | 2016 | 9066 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2004 | 286 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2020 | 18285 | 0.020 |
Why?
|
Models, Chemical | 1 | 2004 | 731 | 0.020 |
Why?
|
Male | 3 | 2020 | 331025 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2005 | 2428 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 26493 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 21779 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 35507 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1313 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 14537 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 3138 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2005 | 2949 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3182 | 0.010 |
Why?
|
Mice | 1 | 2019 | 78424 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 41349 | 0.010 |
Why?
|
Neoplasms | 1 | 2017 | 17009 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 12557 | 0.000 |
Why?
|